CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Allegra Medical Technologies Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Allegra Medical Technologies Ltd
Level 8, 18-20 Orion Road
Phone: +61 291199200p:+61 291199200 SYDNEY, NSW  2066  Australia Fax: +61 294394441f:+61 294394441
On 10/10/2024, the Company was acquired by Allegra Innovations Pty Ltd.
This company is no longer actively traded on any major stock exchange.
Business Summary
Allegra Medical Technologies Limited, formerly Allegra Orthopaedics Limited, is a biotechnology company. The Company is engaged in the medical device industry with its pioneering three dimensional (3D)-printed Sr-HT and Sr-HT-Gahnite orthopedic devices. It holds exclusive ownership of bio ceramic material, along with registered patents and patent applications from the University of Sydney. This material has several applications, including its use as a cervical fusion cage in spinal surgery, offering treatment options for patients. The Company is developing Sr-HT ceramic material to demonstrate the bioactivity required for bone regeneration. Sr-HT-Gahnite features bioactivity, biocompatibility, and mechanical properties suitable for load- bearing orthopedic implants. The primary focus centers on commercializing the Sr-HT Gahnite Bone substitute.
(Source: 10KSB40)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/20236/30/2023Yes----

Industries
SIC Code Description
3841 Surgical and medical instruments and apparatus
3842 Orthopedic, prosthetic, and surgical appliances and supplies

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer JennySwain 5/2/2016 2/14/2011
Company Secretary PatriciaVanni 7/1/2024 7/1/2024
Non-Executive Director NicholasHartnell 3/9/2018 3/9/2018
Non-Executive Independent Director SeanMulhearn 11/19/2015 11/19/2015

General Information
Number of Employees: 4,000 (As of 6/30/2008)
Outstanding Shares: 119,611,028 (As of 12/31/2023)
Shareholders: 521
Stock Exchange: ASX
Fax Number: +61 294394441


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, November 22, 2024